FDA Commissioner Appointment Effort "Interminably Slow" - HHS' Thompson
This article was originally published in The Tan Sheet
Appointment of a new FDA commissioner is unlikely before fall due to the lengthy procedural issues involved in such a nomination, HHS Secretary Tommy Thompson intimated during an appearance at the National Press Club April 17.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC